Mumbai, India, has emerged as a crucial hub for the production of high-quality Budesonide Active Pharmaceutical Ingredient (API), CAS No 51333-22-3. Several established organizations are located within the city, focused on the challenging synthesis of this important corticocopyright. The facilities